During the past decade, Mahavir Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mahavir Hospital" #1 sponsor was "Pfizer" with 2 trials, followed by "St. John's Research Institute" with 2 trials sponsored, "Bio Products Laboratory" with 1 trials sponsored, "Ministry of Science and Technology, India" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mahavir Hospital" #1 collaborator was "Cadila Pharnmaceuticals" with 1 trials as a collaborator, "National Heart and Lung Institute" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Mahavir Hospital" are "Arthritis, Rheumatoid" (2 trials), "Acute Coronary Syndrome" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Idiopathic Thrombocytopenic Purpura" (1 trials) and "Fibromyalgia" (1 trials). Many other conditions were trialed in "Mahavir Hospital" in a lesser frequency.

Most popular intervention types in "Mahavir Hospital" are "Drug" (4 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "CHW based intervention post ACS" (1 trials), "Disease-modifying antirheumatic drug" (1 trials), "Gammaplex, intravenous immunoglobulin" (1 trials) and "Intra-dermal administration of Mycobacterium w" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mahavir Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Mahavir Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mahavir Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mahavir Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".